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Abstract 
Background: Catheter ablation (CA) is a well-known treatment option for patients with symptomatic 
drug-resistant atrial fibrillation (AF). Multiple factors have been identified to determine AF recurrence 
after CA, however their predictive value is rather small. Identification of novel predictors of CA outcome 
is therefore of primary importance to reduce health costs and improve long-term results of intervention. 
The recurrence of AF following CA is related to severity of left ventricular (LV) dysfunction, extent of 
atrial dilatation and fibrosis. The aim of this paper was to present and discuss the latest studies on the 
utility of echocardiographic parameters in terms of CA effectiveness in patients with paroxysmal and 
persistent AF. 
Methods: PubMed, Google Scholar, EBSCO databases were searched for studies reporting echocardio-
graphic preprocedural predictors of AF recurrence after CA. LV systolic and diastolic function, as well 
as atrial size, strain and dyssynchrony were taken into consideration. 
Results: Twenty one full-text articles were analyzed, including three meta-analyses. Several echo-
cardiographic parameters have been reported to determine a risk of AF recurrence after CA. There 
are conventional methods that measure left atrial size and volume, LV ejection fraction, parameters 
assessing LV diastolic dysfunction, and methods using more innovative technologies based on speckle 
tracking echocardiography to determine left atrial synchrony and strain. Each of these parameters has 
its own predictive value. 
Conclusions: Regarding CA effectiveness, every patient has to be evaluated individually to estimate the 
risk of AF recurrence, optimally using a combination of several echocardiographic parameters. (Cardiol 
J XXXX; XX, X: xx–xx)
Key words: atrial fibrillation, catheter ablation, pulmonary vein isolation,  
echocardiography, predictors, recurrence
Introduction
Atrial fibrillation (AF) is the most common 
cardiac arrhythmia with a projected prevalence of 
14–17 million by the year 2030 in the European 
Union [1]. AF remains one of the major causes of 
stroke, heart failure, sudden death, and cardiovas-
cular morbidity. With large increases in the burden 
of AF expected in the coming decades, better 
diagnosis and stratification of treatment selection 
is of paramount importance.
In recent years catheter ablation (CA) became 
a common treatment for patients with sympto-
matic, drug-resistant AF. The success rate of 
CA, defined as no AF relapse, of up to 70% for 
patients with paroxysmal AF and around 50% in 
those with persistent AF [1]. Multiple factors have 
been identified for AF recurrence after CA, such 
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as age, AF duration, ventricular and atrial function 
and comorbidities, however their predictive value 
is rather small [1, 2]. Therefore, new predictors 
of procedural outcome are needed for better iden-
tification of the most suitable candidates for CA.
Optimal patient selection is crucial to avoid 
unnecessary risk associated with CA, which can be 
accompanied by serious complications such as car-
diac tamponade, stroke, pulmonary vein stenosis 
and atrio-esophageal fistula. Finally more accurate 
prediction can influence a decision for continuation 
of long-term oral anticoagulant and antiarrhythmic 
drug therapy. 
Much of the information on ventricular and 
atrial function can be derived from cardiac mag-
netic resonance and tomography, but for practical 
reasons echocardiography is mostly used in clinical 
settings. Active deformation of the heart muscle 
during the cardiac cycle can be assessed with strain 
imaging from two-dimentional speckle tracking 
echocardiography (STE). This technique enables 
the recognition of subtle cardiac dysfunction and 
markers myocardial damage. The ultimate goal of 
these markers is to define different types of AF 
that are characterized by specific pathophysiology 
which may warrant early aggressive intervention 
and will respond favourably to CA. Recurrent AF 
after CA seems to be higher in patients with signs 
of atrial cardiomyopathy, also ventricular function 
plays a major role in the efficacy of this procedure.
The aim of this paper was to present and dis-
cuss the latest studies on echocardiographic param-
eters in terms of CA effectiveness in the treatment 
of patients with paroxysmal and persistent AF.
PubMed, Google Scholar, EBSCO databases 
were searched using the key words “echocardio-
graphic predictors of atrial fibrillation after catheter 
ablation” or “echocardiography atrial fibrillation,” 
“echocardiography pulmonary vein isolation” or 
“echocardiography catheter ablation.” The search 
returned 104 abstracts, published from 1997 to 
2017, all in English. After screening the abstracts, 
42 were included for full-text analysis, according 
to their relevance to the subject. The criteria to 
include studies were as follows: (A) patients with 
paroxysmal or persistent AF referred for CA, (B) 
endpoint analysis taking into account the first re-
currence of AF (defined as any documented episode 
of AF lasting > 30 s). Finally, 21 full-text articles 
were included in relation to CA in patients with 
AF. The following echocardiographic criteria were 
taken into consideration: left (LA) and right atrial 
(RA) size (diameter, area and volume), left ven-
tricular (LV) ejection fraction (LVEF), parameters 
assessing LV diastolic dysfunction, atrial strain and 
dyssynchrony (Table 1). 
Methods
Atrial size
It is established that LA size contributes to 
structural remodeling and therefore to atrial fi-
brosis [3]. Dilatation of the LA is an independent 
predictor of new onset AF [4]. It is also a well-
known predictor of low success for CA in terms of 
AF recurrence [5–7]. 
Zhuang et al. [8] performed a meta-analysis 
of 22 studies which included over 3700 patients, 
which showed that an increased antero-posterior 
diameter of the LA was associated with a higher 
risk of AF recurrence after CA. The antero-pos-
terior diameter of LA before CA, obtained from 
the parasternal long-axis view, was 35–50 mm. In 
patients with arrhythmia recurrences it was 1.87 
mm larger than in those with successful pulmonary 
vein isolation [8]. According to European expert 
consensus from 2012 the LA diameter over 50–55 
mm indicates limited success of CA [6]. In a study 
performed by Liao et al. [9] on 589 patients with 
paroxysmal AF, LA diameter over 43 mm and LV 
systolic diameter over 31 mm were the best cut-
off values for predicting AF progression after CA. 
Their predictive value was highest when both of 
the above-mentioned diameters were exceeded 
[9]. LA dilation can be asymmetric and the antero-
posterior dimension underestimates and does not 
truly reflect LA size. Studies focusing on LA area, 
however, did not confirm its predictive utility. 
Tomas at al. [10] found that LA area > 24 cm2 did 
not predict AF recurrence at 12 month follow up. 
Njoku et al. [11] in a meta-analysis of 21 observa-
tional studies encompassing 3850 patients reported 
that patients with AF recurrence had larger mean 
left atrial volume (LAV) and LAV index (LAVi) 
compared to patients with no arrhythmia relapse. 
Moreover, they found that increased LAV/LAVi 
was independently associated with frequent AF 
recurrences after CA. There was a 3% increase in 
the odds of AF relapse per unit increase in LAV/
LAVi. Shin et al. [12] found that LAVi of 34 mL/
m2 showed a sensitivity of 70% and a specificity of 
91% to predict AF recurrence.
Atrial fibrillation is a biatrial disease. RA, with 
its enlargement and remodeling also involved in 
AF relapse [13]. Moon et al. [13] reported that in-
creased RA volume index (RAVi) might affect early 
AF recurrence (within 3 months) after CA and RAVi 
over 78 mL/m2 predicted the early recurrence with 
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74% sensitivity and 68% specificity [13]. Wen et 
al. [14] found that RA size predicted successful CA 
in patients with paroxysmal AF and LA horizontal 
diameter (determined as the measurement from 
the middle of mitral isthmus to the LA roof in the 
4-chamber apical view) enlargement over 35 mm. 
RA was measured from the middle of tricuspid 
isthmus to the RA roof in the 4-chamber apical 
view, and when this diameter was below 35.5 mm 
it predicted AF recurrence-free survival at over 
2-year follow up. Although a large cohort (over 
400 patients) was examined, the results might be 
applicable only to an Asian population.
Left ventricular systolic function
In previous years several trials comparing 
amiodarone with CA in AF patients with heart 
failure (HF) and reduced ejection fraction (HFrEF) 
showed ablation to be superior at maintaining sinus 
rhythm [15, 16]. However the efficacy of CA in 
HFrEF patients with AF is still a matter of debate. 
Development of AF in HFrEF patients occurs due 
to eccentric remodeling of the LA. In this group an 
increase in LA diameter and volume was observed. 
The underlying electrical substrate driving to AF 
is likely different than in patients with HF and 
preserved ejection fraction, where LA stiffness is 
dominant [17]. 
In a study performed by Cha et al. [18] three 
groups of patients with AF undergoing CA were 
analyzed: 111 with LV systolic dysfunction (LVEF 
≤ 40%), 157 with isolated LV diastolic dysfunction 
(LVEF > 50%) and 100 individuals with normal LV 
function. The authors reported that AF elimination 
rate was significantly lower in patients with systolic 
dysfunction (62%, p = 0.002) and non-significantly 
lower in those with diastolic dysfunction (75%, p = 
0.15) when compared with the group with normal 
LV function. 
Black-Maier et al. [16] compared two groups 
of about 100 patients with LVEF of less and over 
50% and showed no significant differences in the 
rates of atrial arrhythmia recurrence between HF 
patients with preserved and reduced ejection frac-
tion (33.9% vs. 32.6%; p = 0.8) at 1-year follow up. 
The contradictory result may be due to differences 
in the study population enrolled. Patients in the 
Black-Maier et al. [16] study were older and were 
more likely to have hypertension and diabetes 
mellitus.
The efficacy of CA in patients with HFrEF and 
AF was uncertain, until the lately published break-
through CASTLE-AF trial [19]. It was a multicent-
er, randomized, controlled trial to assess whether 
CA lowers morbidity and mortality as compared 
with medical therapy (rate or rhythm control) in 
patients with coexisting AF and medically managed 
HF. The study included almost 400 patients with 
symptomatic paroxysmal or persistent AF and HF 
in the New York Heart Association class II–IV, 
LVEF of 35% or less and an implanted defibrillator. 
Mortality and hospitalization for worsening HF was 
significantly reduced in patients treated with CA. 
After 5 year follow-up sinus rhythm was maintained 
in 63% of patients in the ablation group vs. 22% in 
the medically treated group (p < 0.001). The study 
also revealed that patients with LVEF of less than 
25% were less likely to benefit from ablation than 
those with LVEF between 25% and 35%. It would 
be interesting to determine the success rate of 
CA in patients with advanced HF but preserved 
ejection fraction.
Left ventricular diastolic dysfunction
Left ventricular diastolic dysfunction may in-
dicate an increase in LV filling pressure, which can 
influence LA remodeling over the long term [20]. 
Wall stress due to increased atrial pressure plays an 
important role in the development of atrial electri-
cal and structural remodeling. Impaired diastolic 
function has also been reported to be associated 
with AF recurrences [21]. According to guidelines 
of the American Society of Echocardiography, LV 
diastolic dysfunction can be evaluated and graded 
by mitral inflow assessed by pulsed wave Doppler, 
tissue Doppler of LV walls, and LA size [22].
In 2014 Hirai et al. [23] reported that elevated 
LA pressure, as determined by increased average 
E/e’ index (E — early transmitral flow velocity 
obtained by pulsed wave Doppler; e’— early dias-
tolic mitral velocity measured by tissue Doppler; 
averaged annular septal and lateral values), was the 
only echocardiographic parameter that predicted 
AF recurrence after CA. The E/e’ value over 13 
indicated increased risk of AF relapse during 12 
month follow up.
Three years later Masuda et al. [24] reported 
that patients with E/e’ > 14 before CA more 
frequently developed recurrent atrial tachyar-
rhythmias after single and multiple procedures. 
It was the first study demonstrating that patients 
with high E/e’ ratio, along with age, female sex, 
low body mass index, and persistent AF more fre-
quently presented low-voltage areas within the LA 
predisposing to AF, when endocardial voltage map-
ping was performed during the CA procedure. The 
relationship between higher E/e’ ratio and the pres-
ence of low voltage areas in the LA may indicate 
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that higher E/e’ is associated with advanced atrial 
arrhythmogenic substrate outside the pulmonary 
veins. This  might explain AF recurrences even 
after a properly performed (without reconnections) 
pulmonary vein isolation. 
Finally Okamatsu et al. [25] who examined 
24 patients with hypertrophic cardiomyopathy 
demonstrated that E/e’ ratio was the only predic-
tor of AF recurrence following pulmonary veins 
isolation (PVI). Patients with E/e’ ≥ 15 had a 
significantly higher risk of AF recurrence than 
those with E/e’ < 15. Thus, patients with AF and 
mild or moderate LV diastolic dysfunction (E/e’ < 
15) are better candidates for PVI than those with 
a restrictive inflow pattern.
In a study performed by Onishi et al. [26] 
LV diastolic dysfunction at baseline was the only 
independent risk factor of late AF recurrence, de-
fined as first AF relapse after more than 12 months 
subsequent to CA. The authors defined LV diastolic 
dysfunction very strictly and patients had to fulfill 
all three of the following criteria: early diastolic 
septal annular velocity e’ < 8 cm/s, lateral annular 
velocity e’ < 10 cm/s and LAVi ≥ 34 mL/m2. After 
a single CA procedure, reconnections of pulmonary 
veins could affect recurrence of AF. To minimize 
the influence of pulmonary vein reconnections, 
risk factors of late recurrences after multiple CA 
procedures, not only after a single session were 
examined. LV diastolic dysfunction appeared to be 
the only risk factor of late AF relapses. 
Kosiuk et al. [27] showed that E/A mitral 
inflow pattern (early to late mitral inflow velocity 
ratio, assessed by pulsed-wave Doppler at the level 
of the mitral valve), which is associated with LV 
diastolic dysfunction, was the best pre-procedural 
predictor of short-term AF recurrence during 
the first week after PVI. An E/A ratio of 1.35 was 
the cut-off value with the highest sensitivity and 
specificity for predicting early AF recurrence. In 
contrast to Onishi et al. [26], the authors reported 
that none of the parameters evaluating LV diastolic 
function predicted long-term PVI result (defined as 
any documented AF episode within a 3–12 month 
period after ablation). This discrepancy may be due 
to different definitions of LV diastolic dysfunction 
applied in both studies. Moreover, Kosiuk et al. 
[27] analyzed the results of CA after only a single 
procedure, and it can also explain the contradic-
tory results because, as mentioned above, late 
AF recurrences are mainly due to pulmonary vein 
reconnections [28, 29]. Finally, a limited number of 
patients with severe LV diastolic dysfunction might 
preclude evaluation of other parameters, like E/e’ 
ratio as predictors of both, short- and long-term 
AF recurrences after CA. 
Left atrial strain 
Schneider et al. [30] evaluated results of tissue 
Doppler imaging (TDI)-based LA strain analysis in 
patients with AF for the prediction of successful 
CA. The authors showed that patients with higher 
atrial strain and strain rate after CA appear to have 
a greater likelihood of maintaining sinus rhythm. 
Peak strain and strain rate were measured at each 
mid-LA segment one day prior to, within 24 hours, 
and 3 months after CA. A value of 20% for atrial 
septal systolic strain obtained before the procedure 
predicted sinus rhythm maintenance after CA, but 
with rather low sensitivity (57%) and specificity 
(56%). This method, however, is prone to angula-
tion error and suffers from variable reproducibility. 
Moreover, it does not allow distinguishing active 
myocardial contraction from its passive motion. 
Two-dimensional STE (2D-STE) is angle 
independent and thus more useful for LA strain 
analysis [31]. There are several studies indicating 
that LA strain has higher predictive value than LA 
size obtained from conventional echocardiography 
[31, 32]. The LA strain reflects LA reservoir, con-
duit and booster pump function. Furthermore, it 
correlates with the extent of LA fibrosis, especially 
in patients with persistent AF [7, 33].
A meta-analysis of 8 studies, which included 
686 patients with paroxysmal AF showed that 
global LA strain is useful to identify individuals 
at high risk of AF recurrence after CA [34]. This 
analysis included both patients with sinus rhythm 
or AF at baseline, before PVI. In the group with 
AF, the beginning of QRS was set as the zero strain 
point. In patients with sinus rhythm the trigger for 
strain analysis was put either at the onset of QRS 
complex or P-wave. LA peak positive strain of less 
than 22.8% predicted AF recurrence with 78% 
sensitivity and 75% specificity. These results were 
independent of the applied method of LA strain 
analysis: from the beginning of QRS or P-wave, as 
well as software package used. 
Left atrial strain measured on LA lateral wall 
by 2D-STE might be the most useful parameter 
for predicting successful AF ablation as it repre-
sents pure LA contractile function [35]. Yasuda et 
al. [35] indicated a significant prognostic value of 
basal LA lateral total strain, both in patients with 
sinus rhythm and AF during examination. The au-
thors set the zero strain point at the beginning of 
QRS complex in the group with AF and at P wave 
in the group with sinus rhythm. The total strain 
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was calculated as follows: positive peak strain – 
negative peak strain. They reported that a value 
below 25.3% in basal LA lateral strain showed 81% 
sensitivity and 72% specificity for predicting AF 
recurrence after CA [35].
Most of the studies included in the mentioned 
meta-analysis [34] assessed patients with mainly 
paroxysmal or different types of AF. Parwani et 
al. [36] reported that low LA peak positive strain 
(< 10%) during an episode of persistent AF was 
strongly linked to recurrence of AF after one or 
even after two CA procedures.
Finally, some results suggest that three-
dimensional STE (3D-STE) is potentially more 
accurate than 2D-STE for assessment of LA dys-
function in patients with AF [37, 38]. Mochizuki et 
al. [39] assessed patients with paroxysmal AF and 
found that global LA strain determined by 3D-STE 
less than 28.9% was a predictor of AF recurrence 
after the first-time CA Moreover, 3D-STE global 
LA strain was a better predictor of AF relapse after 
CA than LA strain obtained by 2D-STE. Three-
dimensional strain analysis reflects LA function 
in many directions: not only longitudinal, but also 
circumferential and area strains. This can explain 
its superiority over 2D-STE.
Left atrial mechanical dyssynchrony 
The LA mechanical dyssynchrony, which 
clearly indicates the presence of atrial structural 
and electrical remodeling, can predict recurrence 
of AF after CA in patients with paroxysmal AF [40, 
41]. It can be determined by different echocardio-
graphic methods.
Den Uijl et al. [41] reported that total atrial 
conduction time (PA-TDI), reflecting atrial electri-
cal remodeling, was an independent predictor of 
AF recurrence after PVI. Total atrial conduction 
time was obtained by measuring the time delay 
between the onset of the P-wave on the surface 
electrocardiogram and the peak A’-wave of spec-
tral tissue Doppler tracing on LA lateral wall. The 
prolonged value of 146 ± 20 ms was associated 
with AF recurrence after CA (for comparison 
PA-TDI in healthy subjects was 78 ± 7 ms) [42]. 
Similarly, Fukushima et al. [43] found that PA-TDI 
was an independent predictor of AF recurrence in 
patients with paroxysmal AF. They reported 2.5-
fold higher rate of AF relapses in patients with 
PA-TDI duration > 151.3 ms. Evranos et al. [44] 
demonstrated a relationship between PA-TDI on 
LA lateral wall and recurrence of AF in patients 
treated with cryobaloon ablation. PA-TDI over 125 
ms predicted AF recurrence with 80% sensitivity 
and 90% specificity. Unlike den Uijl et al. [41] they 
defined PA-TDI as a time interval from the onset 
of P wave on the surface electrocardiogram to the 
beginning of the A’ wave. 
Loghin at al. [40], used an algorithm based on 
2D-STE — the vector velocity imaging (VVI) and 
looked at the timing of peak longitudinal strain 
obtained on opposing LA walls during atrial con-
tractile phase. They found that maximum opposing 
walls delay of over 51 ms predicted AF recurrence 
after CA with 89% sensitivity and 72% specificity. 
Unfortunately, the study was retrospective and 
based on a small cohort of 25 patients.
Sarvari et al. [45] measured the dispersion 
of LA contraction duration, defined as the time 
difference from the peak of P wave on the surface 
electrocardiogram during sinus rhythm to maxi-
mum LA shortening assessed by 2D-STE strain 
(peak negative longitudinal strain). The standard 
deviation of contraction durations measured in 
18 LA segments was defined as LA mechanical 
dispersion. The authors reported that patients 
with AF relapse and normal (LAV 25 ± 10 mL/m2) 
presented with significantly greater LA mechanical 
dispersion compared with patients after success-
ful CA (38 ± 14 ms vs. 30 ± 12 ms; p < 0.001). 
Therefore LA mechanical dispersion can be a useful 
tool to predict AF recurrence after CA in patients 
with structurally normal heart. 
Functional mitral regurgitation
Qiao et al. [46] reported that functional mitral 
regurgitation, defined as regurgitation jet area to 
LA area ratio ≥ 0.1 in subjects without any pri-
mary valvular disease, independently predicted 
long-term outcomes post ablation in patients with 
paroxysmal AF. Functional mitral regurgitation was 
strongly correlated with the presence and extent 
of low voltage zones within the LA, assessed in-
vasively prior to ablation.
Conclusions
Several echocardiographic parameters have 
been reported to determine the risk of AF recur-
rence after CA. These parameters reflect morphol-
ogy, function and myocardial remodeling in patients 
with AF. There are conventional methods that 
measure LA size and volume, LVEF, parameters 
assessing LV diastolic dysfunction, and methods 
using more innovative technologies based on STE 
to determine LA synchrony and strain. Each of 
these parameters has their own predictive value. 
Unfortunately, there is no single parameter that 
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actually enables the prediction of AF relapse after 
CA. To summarize, the predictors of AF recur-
rence after CA which were confirmed by several 
groups were LA diameter > 50–55 mm or LAVi 
> 34 mL/m2, E/e’ > 13–15, LA strain assessed by 
STE < 20–25% and total atrial conduction time 
measured by TDI > 150 ms. The presence of LV 
systolic dysfunction also lowered CA success rate 
with a bottom LVEF cut-off value of < 25%. It 
needs underlining that risk of AF recurrence after 
CA should be estimated individually, optimally on 
the basis of several echocardiographic parameters.
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